SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced it will
participate as a double diamond sponsor at the Scoliosis Research
Society (SRS) 54th Annual Meeting held September 18-21, 2019 in Montréal, Canada.
"NuVasive is committed to building the leading complex deformity
portfolio in spine and we are pleased to continue our support of
the Scoliosis Research Society as a double diamond sponsor," said
Matt Link, president of NuVasive.
"We continue to introduce best-in-class technology, leverage key
strategic partnerships, and procedurally integrate our solutions
for complex adult and pediatric deformity to deliver improved
surgical outcomes for this high-risk patient population. We look
forward to showcasing our innovation at the SRS annual
meeting."
NuVasive will host a lunch workshop, Are you leaving
correction on the table? Using Surgical Intelligence technology to
address alignment in pediatric spinal deformity presented by
Drs. David Clements, Greg Mundis, Amer
Samdani and John Vorhies. The
workshop will highlight the integration of enabling technologies,
which are aimed at helping surgeons reproducibly achieve desired
sagittal and coronal alignment. Presenters will discuss techniques
to leverage the Reline® 5.0-6.0mm fixation system and
the Pulse™ platform to receive real-time feedback that helps
objectively measure and dial in correction. The workshop will take
place on Thursday, September 19 from
12:50 to 2:20 p.m. EDT in Room 518 of
the Palais des congrès de Montréal.
NuVasive will also demonstrate several of its technologies,
including:
- X360™ system - Comprehensive approach to lateral
single-position surgery, which leverages advanced techniques and
technologies to deliver patient-specific care, while enhancing
operating room workflow and efficiency.
- Pulse platform - Integrated technology that includes
neuromonitoring, global alignment, radiation reduction, imaging and
navigation functions, with extensible capabilities for robotics and
smart tools, designed to help surgeons adopt more efficient, less
invasive surgical approaches.1
- Complex spinal deformity portfolio - Solutions include
VersaTie®, a posterior band system designed to provide
clinical versatility and flexibility in the treatment of complex
spinal pathologies and Bendini®, a proprietary, digital
spinal rod bending system used to create patient-specific
rods.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, focused on transforming spine surgery and beyond with
minimally disruptive, procedurally integrated solutions designed to
deliver reproducible and clinically-proven surgical outcomes. The
Company's portfolio includes access instruments, implantable
hardware, biologics, software systems for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative monitoring
service offerings. With more than $1
billion in revenues, NuVasive has approximately 2,600
employees and operates in more than 50 countries serving surgeons,
hospitals and patients. For more information, please visit
www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical
results or those expressed or implied by such forward-looking
statements. The potential risks and uncertainties which contribute
to the uncertain nature of these statements include, among others,
risks associated with acceptance of the Company's surgical products
and procedures by spine surgeons, development and acceptance of new
products or product enhancements, clinical and statistical
verification of the benefits achieved via the use of NuVasive's
products (including the iGA® platform), the Company's
ability to effectually manage inventory as it continues to release
new products, its ability to recruit and retain management and key
personnel, and the other risks and uncertainties described in
NuVasive's news releases and periodic filings with the Securities
and Exchange Commission. NuVasive's public filings with the
Securities and Exchange Commission are available at www.sec.gov.
NuVasive assumes no obligation to update any forward-looking
statement to reflect events or circumstances arising after the date
on which it was made.
1 Certain applications of the Pulse platform are
under development and not available for commercial sale; robotics
and smart tools are not cleared for use by the FDA.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-participate-as-double-diamond-sponsor-at-scoliosis-research-society-annual-meeting-300915477.html
SOURCE NuVasive, Inc.